NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Cambridge cut ties with Flock Safety. Days later, an MIT professor was killed — and the suspect was found using Flock’s tech.Read More